Released on: July 9, 2008, 3:11 am

Press Release Author: Shushmul Maheshwari

Industry: Pharmaceuticals

Press Release Summary: RNCOS has recently added a new Market Research Report titled,
\"Generic Drug Market in Canada\" to its report gallery. Canada represents one of the
largest markets for pharmaceuticals in the world, with a huge potential for
generics.

Press Release Body: RNCOS has recently added a new Market Research Report titled,
\"Generic Drug Market in Canada\" to its report gallery. Canada represents one of the
largest markets for pharmaceuticals in the world, with a huge potential for
generics. Generics in 2007 accounted for more then 46% prescriptions and 19% sales
out of the total pharmaceutical market. The market is currently being driven by
several factors, such as patent expiry of several blockbuster drugs, lower costs,
cost containment measures by the government, and rapidly ageing population.

The report thoroughly evaluates the factors that distinguish Canada from all other
generic markets both in positive and negative ways. A major factor that
differentiates the Canadian generic market from the US and most European markets is
the comparatively high price of generics and lower price erosion. This allows
manufacturers to fetch better margins from their drugs, and is a major reason which
is attracting foreign players to enter this market.

Currently, drugs against chronic diseases occupy most of the pharmaceutical market,
with cardiovascular drugs holding the top spot. However, strong growth is expected
in other chronic segments also, particularly in cancer and diabetes.

Although the market has huge potential, growth can be significantly hampered by
recent government regulations and various other challenges. However, the low cost of
generics, coupled with billion dollar drug patent expiries, is expected to enable
the generic market to continue its double-digit growth in the next five years.

Key Findings

- The penetration of generics is rapidly increasing in the Canadian pharmaceutical
market, with generics expected to account for nearly 26% of the entire
pharmaceutical sales by 2012.
- Apotex has been the leader of the Canadian generic market, controlling around 34%
of the market in 2006.
- Nearly 5 Million people in Canada will be above 65 years by 2011, increasing the
demand for drugs, specifically those for chronic diseases.
- Generics substitution is preferred by pharmacists as they give better returns than
branded drugs.
- The top four generic companies presently control more then 70% of the generic
market, but the market is expected to undergo more fragmentation in future.
- Projected growth of generics at a CAGR of 14% during 2007-2012 will surpass that
of pharmaceutical market at a CAGR 7.6% during the same period.

Key Issues & Facts Analyzed

- Evaluation of past, current and future market trends.
- Discussion about the size and growth of the market.
- Study of various distribution channels prevailing in the market.
- Analysis of healthcare indicators.
- Future prospects of the generic market.
- Profile discussion of key players in this market.
- Analysis of various challenges and opportunities for the market.

Key Players Analyzed

This section provides the overview, key facts, and financial information of
prominent players in the Canadian generic market, including Teva Pharmaceutical
Industries Limited, Apotex Inc, Ratiopharm GmBH, Pharmascience Inc., etc.

Research Methodology Used

Information Sources
Information has been sourced from books, newspapers, trade journals, and white
papers, industry portals, government agencies, trade associations, monitoring
industry news and developments, and through access to over 3000 paid databases.

Analysis Methods
The analysis methods include ratio analysis, historical trend analysis, linear
regression analysis using software tools, judgmental forecasting, and cause and
effect analysis.

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit: http://rncos.com/Report/IM598.htm
Current Industry News: http://www.rncos.com/Blog/

Web Site: http://www.rncos.com

Contact Details: 29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
91-11-4214-1228
info@rncos.com

http://www.rncos.com/